Guggenheim analyst Vamil Divan lowered the firm’s price target on AbbVie (ABBV) to $212 from $221 and keeps a Buy rating on the shares. The ...

AbbVie Inc (NYSE:ABBV)., a leading biopharmaceutical company, stands at a critical juncture as it navigates the loss of ...

Merck stock (NYSE: MRK) lost about 10% in 2024, underperforming the broader S&P 500 index, which gained 23% for the year.

Medicare has announced 15 new drugs up for price negotiations, set to begin in the next several months with top drugmakers, ...

UBS Group AG has removed Credit Suisse’s signs at its one-time arch-rival’s former headquarters in Zurich, replacing them ...

Seven-Market Drug Forecast Analysis - Update" report has been added to ResearchAndMarkets.com's offering. Market Growth Driven by Aging Populations and Innovative TherapiesThe global glaucoma market ...

Israel and Hamas Work Out Differences Over Deal, Netanyahu Says Prime Minister Benjamin Netanyahu ordered a meeting of Israel’s political security cabinet to vote on the Gaza cease-fire deal. A ...

Israeli Security Cabinet Meets to Vote on Gaza Cease-Fire Deal Prime Minister Benjamin Netanyahu urged the security cabinet to approve the agreement after a day of delays. The deal could go into ...

The biggest stories of the day delivered to your inbox.

Teva Pharmaceutical Industries Ltd. ADR-0.51% $24.5B ...

“We are not the enemy of the people. We are the defenders of the people,” Acosta told viewers Thursday night.

Covering Netflix News Independently Since 2013. What’s on Netflix is not owned by or affiliated with Netflix or any of its partners in any capacity. The authors of this site also have no affiliation ...